FIRST ORAL TREATMENT FOR CROHN'S DISEASE APPROVED

被引：0
|
作者：
Aschenbrenner, Diane S.
机构：
来源：
AMERICAN JOURNAL OF NURSING | 2023年 / 123卷 / 09期
关键词：
D O I：
10.1097/01.NAJ.0000978128.39810.2a
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Upadacitinib (Rinvoq), the first oral treatment for Crohn's disease, has been approved.Nurses and NPs should follow the warnings listed on the drug's labeling for all uses. Patients should be told to avoid grapefruit and grapefruit juice to prevent adverse drug reactions.
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [41] Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer’s disease treatment
    Jinwei Zhang
    Inflammation Research, 2023, 72 : 1873 - 1876
  • [42] Crohn's Disease And Its Oral Manifestations
    Malathi, L.
    Mangai, T. Alamelu
    Anitha, N.
    Rajesh, E.
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2021, : 79 - 82
  • [43] Oral budesonide in the management of Crohn's disease
    Hofer, KN
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (10) : 1457 - 1464
  • [44] Oral and upper gastrointestinal Crohn's disease
    Laube, Robyn
    Liu, Ken
    Schifter, Mark
    Yang, Jessica L.
    Suen, Michael K.
    Leong, Rupert W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (02) : 355 - 364
  • [45] Orofacial Crohn's Disease: An Oral Enigma
    Fatahzadeh, Mahnaz
    Schwartz, Robert A.
    Kapila, Rajendra
    Rochford, Christopher
    ACTA DERMATOVENEROLOGICA CROATICA, 2009, 17 (04) : 289 - 300
  • [46] Symptomatic Oral Crohn's Disease in an Adolescent
    Schmitz, Brian A.
    Unkel, John H.
    JOURNAL OF DENTISTRY FOR CHILDREN, 2018, 85 (02): : 66 - 69
  • [47] An Atypical Case of Oral Crohn's Disease
    Marino, Danielle E.
    Pope-Collins, Elizabeth
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1162 - S1162
  • [48] Coincidental oral lesions in Crohn's disease
    Zhou, Lifeng
    Wei, Li
    Guo, Xiaoguang
    Long, Qiongxian
    Ming, Huawei
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2024, 116 (08)
  • [49] First COMT inhibitor approved for Parkinson's disease
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (06) : 524 - +
  • [50] Adalimumab in Crohn's disease patients: pharmacokinetics in the first 6 months of treatment
    Lie, M. R. K. L.
    Peppelenbosch, M. P.
    West, R. L.
    Zelinkova, Z.
    van der Woude, C. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (10) : 1202 - 1208
12345